Cajal Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Cajal Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults. (NCT07577817) | Cajal Therapeutics Inc. | 2026-06-01 |
Track Cajal Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.